Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases
Neurological diseases (NDs) are a significant cause of disability and death in the global population. However, effective treatments still need to be improved for most NDs. In recent years, cell-membrane-coated nanoparticles (CMCNPs) as drug-targeting delivery systems have become a research hotspot....
Main Authors: | Jianzhuang Li, Yanhao Wei, Chunlin Zhang, Rentang Bi, Yanmei Qiu, Yanan Li, Bo Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/2/621 |
Similar Items
-
Preclinical Research on Focused Ultrasound-Mediated Blood–Brain Barrier Opening for Neurological Disorders: A Review
by: Chanho Kong, et al.
Published: (2023-02-01) -
Special delEVery: Extracellular Vesicles as Promising Delivery Platform to the Brain
by: Marie J. Pauwels, et al.
Published: (2021-11-01) -
Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders
by: Abdul Waris, et al.
Published: (2022-06-01) -
Brain-targeted drug delivery assisted by physical techniques and its potential applications in traditional Chinese medicine
by: Yunbo Sun, et al.
Published: (2021-07-01) -
Nanogels as novel drug nanocarriers for CNS drug delivery
by: V. Manimaran, et al.
Published: (2023-08-01)